ORYZON announces First Patient In in NET, a collaborative Ph

ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas

Related Keywords

United States , Spain , Barcelona , Comunidad Autonoma De Cataluna , Douglas Faller , Namrata Vijayvergia , Development Agreement , Us National Cancer Institute , Nuclear Dynamics , Cancer Epigenetics Institute , Fox Chase Cancer Center , Oryzon Genomics , Assistant Chief , Gastrointestinal Medical Oncology , Global Chief Medical Officer , Small Cell Lung Cancer , Personalized Medicine , Cancer Cell , Fim Phase , Cooperative Research , Cancer Institute , Spanish Comisi , Nacional Del Mercado De Valores , Neuroendocrine Carcinomas Nec , Iadademstat , Oryzon Genomics Sa ,